Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial. [electronic resource]
Producer: 20180917Description: 130-137 p. digitalISSN:- 1879-0046
- Adrenergic Uptake Inhibitors -- adverse effects
- Adult
- Amphetamine-Related Disorders -- drug therapy
- Atomoxetine Hydrochloride -- adverse effects
- Behavior Therapy
- Buprenorphine -- adverse effects
- Buprenorphine, Naloxone Drug Combination -- therapeutic use
- Depression -- drug therapy
- Double-Blind Method
- Humans
- Male
- Middle Aged
- Narcotic Antagonists -- adverse effects
- Opioid-Related Disorders -- drug therapy
- Pilot Projects
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.